The URL can be used to link to this page

Browse Search

Home My WebLink About20212393.tiffRESOLUTION RE: APPROVE FDP COST REIMBURSEMENT SUBAWARD AGREEMENT FOR HPV FREE COLORADO PROJECT AND AUTHORIZE CHAIR TO SIGN - DENVER HEALTH AND HOSPITAL AUTHORITY (DHHA) WHEREAS, the Board of County Commissioners of Weld County, Colorado, pursuant to Colorado statute and the Weld County Home Rule Charter, is vested with the authority of administering the affairs of Weld County, Colorado, and WHEREAS, the Board has been presented with a FDP Cost Reimbursement Subaward Agreement for the HPV (Human Papillomavirus) Free Colorado Project between the County of Weld, State of Colorado, by and through the Board of County Commissioners of Weld County, on behalf of the Department of Public Health and Environment, and Denver Health and Hospital Authority (DHHA), commencing July 1, 2021, and ending June 30, 2022, with further terms and conditions being as stated in said agreement, and WHEREAS, after review, the Board deems it advisable to approve said agreement, a copy of which is attached hereto and incorporated herein by reference. NOW, THEREFORE, BE IT RESOLVED by the Board of County Commissioners of Weld County, Colorado, that the FDP Cost Reimbursement Subaward Agreement for the HPV (Human Papillomavirus) Free Colorado Project between the County of Weld, State of Colorado, by and through the Board of County Commissioners of Weld County, on behalf of the Department of Public Health and Environment, and Denver Health and Hospital Authority, be, and hereby is, approved. BE IT FURTHER RESOLVED by the Board that the Chair be, and hereby is, authorized to sign said agreement. The above and foregoing Resolution was, on motion duly made and seconded, adopted by the following vote on the 9th day of August, A.D., 2021, nunc pro tunc July 1, 2021. BOARD OF COUNTY COMMISSIONERS WELD COUNTY, COLORADO ATTEST: ddat,,,, ,reito;eik Weld County Clerk to the Board County Attorney Date of signature: OA'/16/2( Steve M+reno, air mes, Pro-Te ike Freeman cc:HL(r6) Qg/17/21 2021-2393 HL0053 /9 Memorandum TO: Steve Moreno, Chair Board of County Commissioners FROM: Mark Lawley, Executive Director Department of Public Health & Environment DATE: July 22, 2021 SUBJECT: Alliance for HPV Free Colorado Subaward Agreement with Denver Health & Hospital Authority For the Board's approval is the FY21-22 HPV Free Colorado Subaward Agreement between the Denver Health and Hospital Authority (DHHA) and the Weld County Board of Commissioners for the benefit and use of the Weld County Department of Public Health and Environment (WCDPHE). The Alliance for HPV Free Colorado is a collaborative project funded by the Cancer Cardiovascular and Chronic Pulmonary Disease Grants Program working to decrease rates of the Human Papillomavirus (HPV) in a 15 -county region across Colorado. The goal is to implement a multidisciplinary, socioecological approach that results in a sustainable increase in completion of the HPV vaccine series for eleven to seventeen -year -olds. These funds will be used to promote and champion HPV vaccine education and awareness, implement a health systems approach to increase adherence to national HPV vaccination guidelines among practices and providers, implement a targeted communication plan for parents of teens, and measure HPV vaccination rates, which have increased in Weld County since our participation in this project. With the approval of this contract, Weld County will be reimbursed up to $40,244.00 by Denver Health and Hospital Authority for the project term of July 1, 2021, through June 30, 2022. No new FTE will be required to perform the deliverables under this collaborative agreement with DHHA, they can be met with existing staff Assistant County Attorney, Karin McDougal, has reviewed this Agreement and has determined that its terms are acceptable. Four of the five Board members approved placement of this Agreement on the Board's agenda via pass -around dated July 19, 2021. I recommend approval of this HPV Free Colorado Subaward Agreement with DHHA. 2021-2393 HLG053 BOARD OF COUNTY COMMISSIONERS PASS -AROUND REVIEW TITLE: Alliance for HPV Free Colorado Subaward Agreement with Denver Health & Hospital Authority DEPARTMENT: PUBLIC HEALTH & ENVIRONMENT PERSON REQUESTING: Mark Lawley, Executive Director DATE: July 19, 2021 Brief description of the problem/issue: Enclosed for the Board's review and approval is the FY21-22 HPV Free Colorado Subaward Agreement between the Denver Health and Hospital Authority (DHHA) and the Weld County Board of Commissioners for the benefit and use of the Weld County Department of Public Health and Environment (WCDPHE). The Alliance for HPV Free Colorado is a collaborative project funded by the Cancer Cardiovascular and Chronic Pulmonary Disease Grants Program working to decrease rates of the Human Papillomavirus (HPV) in a 15 -county region across Colorado. The goal is to implement a multidisciplinary, socioecological approach that results in a sustainable increase in completion of the HPV vaccine series for eleven to seventeen -year - olds. These funds will be used to promote and champion HPV vaccine education and awareness, implement a health systems approach to increase adherence to national HPV vaccination guidelines among practices and providers, implement a targeted communication plan for parents of teens, and measure HPV vaccination rates, which have increased in Weld County since our participation in this project. Healthy People 2030 has a goal to increase the proportion of adolescents who receive the recommended doses of HPV vaccine to 80%. Currently, approximately 42% of teens aged 11-17 years are fully vaccinated against HPV in Weld County and 46% state-wide, which are both increases since last year. Through collaboration with our community and regional partners, which includes standardized messaging, we can help continue to improve these statistics. With the approval of this contract, Weld County will be reimbursed up to $40,244.00 by Denver Health and Hospital Authority for the project term of July 1, 2021, through June 30, 2022. No new FTE will be required to perform the deliverables under this collaborative agreement with DHHA, they can be met with existing staff. What options exist for the Board? (include consequences, impacts, costs, etc. of options): Approval of this contract with DHHA will provide funding to allow WCDPHE to be part of the solution to increase HPV vaccination rates among eleven to seventeen -year -olds in Weld County and Colorado. Declining this contract will result in lower than acceptable HPV vaccination rates for Weld County and Colorado and as a result, possibly an increase in preventable HPV cancers. Recommendation: I recommend approval of this HPV Free Colorado Subaward Agreement with DHHA. Approve Recommendation Perry L. Buck Mike Freeman Scott K. James, Pro -Tern Steve Moreno, Chair Lori Saine Schedule Work Session Other/Comments: DocuSign Envelope ID: BE296F94-60BA-4CE9-877E-CEAD4C9D575D FDP Cost Reimbursement Subaward Agreement Prime Sponsor (Non-federal): Colorado Department of Public Health Pass -Through Entity (PTE): Subrecipient: Denver Health and Hospital Authority Weld County Department of Public Health and Environment PTE PI: Judith Shlay Sub PI: N/A Prime Sponsor Award # 2019-"0127 Amend #1 Subaward No: A18 -0055 -S008 -A02 Project Title: HPV Free Colorado Subaward Period of Performance (Budget pei odl: Amount Funded This Action (USD): $ 40,244.00 Start: 07/01/2021 End: 06/30/2022 Estimated Project Period (if incrementally f rieril• Incrementally (USD): Estimated Total USD : $)120,326.00 Start: 107/01/2019 I End: L08/30/2022 Terms and Conditions 1. PTE hereby awards a cost reimbursable subaward, as described above, to Subrecipient. The Statement of Work and budget for this Subaward are as shown in Attachment 5. In its performance of Subaward work, Subrecipient shall be an independent entity and not an employee or agent of PTE. 2. Subrecipient shall submit invoices nail more often than monthly and not less frequently than quarterly for allowable costs incurred. Upon the receipt of proper invoices, the PTE agrees to process payments in accordance with this Subaward and 2 CFR 200.305. All invoices shal be submitted using Subrecipient's standard invoice, but at a minimum shall include current and cumulative costs (including cost sharing), Subaward number, and certification, as required in 2 CFR 200.415 (a). Invoices that do not reference PTE Subaward number shall be returned to Subrecipient. Invoices and questions concerning invoice receipt or payments shall be directed to the party's' Administrative 'Contact, shown in Attachment 3A. 3. A final statement of cumulative costs incurred, including cost sharing, marke " INAL" must be submitted to PTE's 'Administrative ontact, as shown in Attachment 3A, not later than 35 ays after the Budget Period end date. The final statement of costs shall constitute Subrecipient's final financial report. 4. All payments shall be considered provisional and are subject to adjustment within the total estimated cost in the event such adjustment is necessary as a result of an adverse audit finding against the Subrecipient. 5. Matters concerning the technical performance of this Subaward shall be directed to the appropriate party's Principal Investigator as shown in Attachments 3A and 3B. Technical reports are required as shown in Attachment 4. 6. Matters concerning the request or negotiation of any changes in the terms, conditions, or amounts cited in this Subaward, and any changes requiring prior approval, shall be directed to each party's Financial Contact, as shown in Attachments 3A and 3B. Any such change made to this Subaward requires the written approval of each party's Authorized Official, as shown ii Attachments 3A and 3B. 7. The PTE may issue non -substantive changes to the Period of Performance and budget Unilaterally Unilateral modification shall be considered valid 14 days after receipt unless otherwise indicated by Subrecipient when sent to Subrecipient's Authorized Official Contact, as shown in Attachment 3B. 8. Each party shall be responsible for its negligent acts or omissions and the negligent acts or omissions of its employees, officers, or directors, to the extent allowed by law. 9. Either party may terminate this Subaward with 30 days written notice to the appropriate party's Authorized Official Contact, as shown in Attachments 3A and 3B. PTE shall pay Subrecipient for termination costs as allowable under Uniform Guidance, 2 CFR 200, or 45 CFR Part 75 Appendix IX, as applicable. 10. By signing this Subaward, including the attachments hereto which are hereby incorporated by reference, Subrecipient certifies that it will perform the Statement of Work in accordance with the terms and conditions of this Subaward and the applicable terms of the Prime Agreement. The parties further agree that they intend this Subaward to comply with all applicable laws, regulations and requirements. By an Authorized Official of Pass -through Entity: ,—UoospnIMby. 8/9/2021 I 3:46 PM PDT By an Authorized Official of Subrecipient: oocuSigndby, 8/9/2021 I 12:48 PM MDT Q�ain.p.a. exult)", 61tmt, eith tekb '—0ACDB82 +7 E74B8D8 Name: Amanda Breeden Date Name: e Moreno Date Title: Director, SPARO Title: chaff r 1 0Zoot1-x-393 FDP OCT 2018 DocuSign Envelope ID: BE296F94-60BA-4CE9-877E-CEAD4C9D575D Attachment 1 Certifications and Assurances Subaward Number: A18 -0055 -S008 -A02 Certification Regarding Lobbying (2 CFR 200.450) By signing this Subaward, the Subrecipient Authorized Official certifies, to the best of his/her knowledge and belief, that no Federal appropriated funds have been paid or will be paid, by or on behalf of the Subrecipient, to any person for influencing or attempting to influence an officer or employee of any agency, a Member of Congress, an officer or employee of Congress, or an employee of a Member of Congress in connection with the awarding of any Federal contract, the making of any Federal grant, the making of any Federal loan, the entering into of any cooperative agreement, and the extension, continuation, renewal, amendment, or modification of any Federal contract, grant, loan, or cooperative agreement in accordance with 2 CFR 200.450. If any funds other than Federal appropriated funds have been paid or will be paid to any person for influencing or intending to influence an officer or employee of any agency, a Member of Congress, an officer or employee of Congress, or an employee of a Member of Congress in connection with this Federal contract, grant, loan, or cooperative agreement, the Subrecipient shall complete and submit Standard Form -LLL, "Disclosure Form to Report Lobbying," to the PTE. This certification is a material representation of fact upon which reliance was placed when this transaction was made or entered into. Submission of this certification is a prerequisite for making or entering into this transaction imposed by 31 U.S.C. 1352. Any person who fails to file the required certification shall be subject to a civil penalty of not less than $10,000 and not more than $100,000 for each such failure. Debarment, Suspension, and Other Responsibility Matters (2 CFR 200.213 and 2 CFR 180) By signing this Subaward, the Subrecipient Authorized Official certifies, to the best of his/her knowledge and belief that neither the Subrecipient nor its principals are presently debarred, suspended, proposed for debarment, declared ineligible or voluntarily excluded from participation in this transaction by any federal department or agency, in accordance with 2 CFR 200.213 and 2 CFR 180. Audit and Access to Records Per 2 CFR 200.501- 200.521, Subrecipient certifies that it will provide notice of any adverse findings which impact this Subaward and will provide access to records as required by parts 2 CFR 200.336, 200.337, and 200.201 as applicable. If Subrecipient is not subject to the Single Audit Act, then Subrecipient will provide notice of the completion of any required audits and provide access to such audits upon request. Program for Enhancement of Contractor Employee Protections (41 U.S.C 4712) Subrecipient is hereby notified that they are required to: inform their employees working on any federal award that they are subject to the whistleblower rights and remedies of the pilot program; inform their employees in writing of employee whistleblower protections under 41 U.S.C §4712 in the predominant native language of the workforce; and include such requirements in any agreement made with a subcontractor or subgrantee. The Subrecipient shall require that the language of the certifications above in this Attachment 1 be included in the award documents for all subawards at all tiers (including subcontracts, subgrants, and contracts under grants, loans, and cooperative agreements) and that all subrecipients shall certify and disclose accordingly. Use of Name Neither party shall use the other party's name, trademarks, or other logos in any publicity, advertising, or news release without the prior written approval of an authorized representative of that party. The parties agree that each party may use factual information regarding the existence and purpose of the relationship that is the subject of this Subaward for legitimate business purposes, to satisfy any reporting and funding obligations, or as required by applicable law or regulation without written permission from the other party. In any such statement, the relationship of the parties shall be accurately and appropriately described. DocuSign Envelope ID: BE296F94-60BA-4CE9-877E-CEAD4C9D575D Attachment 2 Prime Award Terms and Conditions Required Data Elements The data elements required by Uniform Guidance are incorporated' as entered. This Subaward Is: I Research & Development Service Subaward Number A18 -0055 -S008 -A02 Federal Award Issue Date FAIN CFDA No. [N/A N/A CFDA Title N/A Key Personnel per Prime Agreement General Terms and Conditions By signing this Subaward, Subrecipient agrees to the following: 1. To abide by the conditions on activities and restrictions on expenditure of sponsored funds in appropriations acts that are applicable to this Subaward to the extent those restrictions are pertinent. This includes any recent legislation noted on the Snnnsor's website. 2. 2 CFR 200 3. The Sponsor's grants policy guidance, including addenda in effect as of the beginning date of the period of performance or as amended found at: 4. Research Terms and Conditions, including any Sponsor's specific requirements found at: N/A except for the following : a. No -cost extensions require the written approval of the PTE. Any requests for a no -cost extension shall be directed to the Financial Contact shown in Attachment 3A, not less than 30 days prior to the desired effective date of the requested change. b. Any payment mechanisms and financial reporting requirements described in the applicable Sponsor Terms and Conditions and are replaced with Terms and Conditions (1) through (4) of this Subaward; and c. Any prior approvals are to be sought from the PTE and not the Sponsor. d. Title to equipment as defined in 2 CFR 200.33 that is purchased or fabricated with research funds or Subrecipient cost sharing funds, as direct costs of the project or program, shall vest in the Subrecipient subject to the conditions specified in 2 CFR 200.313. e. Prior approval must be sought for a change in Subrecipient PI or change in Key Personnel (defined as listed in the Prime Award). 5. Treatment of program income: Additive This section intentionally left blank Special Terms and Conditions: Copyrights: Subrecipient grants to PTE an irrevocable, royalty -free, non -transferable, non-exclusive right and license to use, reproduce, make derivative works, display, and perform publicly any copyrights or copyrighted material (including any computer software and its documentation and/or databases) first developed and delivered under this Subaward solely for the purpose of and only to the extent required to meet PTE's obligations to the Sponsor under its Prime Award. Subrecipient grants to PTE the right to use any written progress reports and deliverables created under this Subaward solely for the purpose of and only to the extent required to meet PTE's obligations to the Sponsor under its Prime Award. Data Rights: Subrecipient grants to PTE the right to use data created in the performance of this Subaward solely for the purpose of and only to the extent required to meet PTE's obligations to the Sponsor under its Prime Award. Data Sharing and Access (Check if applicable): flSubrecipient agrees to comply with the Sponsor's data sharing and access requirements as reflected in the Prime Award (or in I the special terms below) and the Data Management/Sharing Plan submitted to the Sponsor and [attached. DocuSign Envelope ID: BE296F94-60BA-4CE9-877E-CEAD4C9D575D Promoting Objectivity in Research (COI): Subrecipient must designate herein which entity's Financial Conflicts of Interest policy (COI) will apply: Subrecipient If applying its own COI policy, by execution of this Subaward, Subrecipient certifies that its policy complies with the requirements of the relevant Federal Awarding Agency as identified herein: 142 CFR Part 50 Subpart F Subrecipient shall report any financial conflict of interest to PTE's Administrative Representative or COI contact, as designated on Attachment 3A. Any financial conflicts of interest identified shall, when applicable, subsequently be reported to Federal Awarding Agency. Such report shall be made before expenditure of funds authorized in this Subaward and within 45 days of any subsequently identified COI. Work Involving Human or Vertebrate Animals (Select Applicable Options) nHuman Subjects n Vertebrate Animals n No Human or Vertebrate Animals Subrecipient agrees that any non-exempt human and/or vertebrate animal research protocol conducted under this Subaward shall be reviewed and approved by its Institutional Review Board (IRB) and/or its Institutional Animal Care and Use Committee (IACUC), as applicable and that it will maintain current and duly approved research protocols for all periods of the Subaward involving human and/or vertebrate animal research. Subrecipient certifies that its IRB and/or IACUC are in full compliance with applicable state and federal laws and regulations. The Subrecipient certifies that any submitted IRB / IACUC approval represents a valid, approved protocol that is entirely consistent with the Project associated with this Subaward. In no event shall Subrecipient invoice or be reimbursed for any human or vertebrate animals related expenses incurred in a period where any applicable IRB / IACUC approval is not properly in place. Human Subjects Data (Select One) Not Applicable This section left intentionally blank Additional Terms In connection with the performance of work under this contract, SUBRECIPIENT may not refuse to hire, discharge, promote or demote, or discriminate in matters of compensation against any person otherwise qualified, solely because of race, color, religion, national origin, gender, age, military status, sexual orientation, gender identity or gender expression, marital status, or physical or mental disability. SUBRECIPIENT shall insert the foregoing provision in all subcontracts. All invoices must also include a unique invoice number and "pay to" information in order to be paid. Invoices that do not reference these items, as well as PTE Subaward number, shall be returned to Subrecipient. DocuSign Envelope ID: BE296F94-60BA-4CE9-877E-CEAD4C9D575D i _ Attachment 3A Pass -Through Entity (PTE) Contacts i Subaward Number: Al8-0055-S008-A02 PTE Information Entity Name: Legal Address: Website: Denver Health and Hospital Authority 777 Bannock Street Denver, CO 80204-4057 www.denverhealth.org PTE Contacts Central Email: Principal Investigator Name: Email: sparo@dhha.org Judith Shlay Judith.Shlay@dhha.org Administrative Contact Name: Email: Telephone Number: 303-602-3714 Soukayna Iraqi Soukayna.lragi@dhha.org COI Contact email (if different to above): Financial Contact Name: Email: Email invoices?® Yes © No Invoice email (if different): Telephone Number: 303-602-8734 sparo@dhha.org Tamara Wilde Tamara.Wilde@dhha.org Authorized Official Name: Email: PI Address: Telephone Number: 303-602-7063 Nikki.Pham@dhha.org Amanda Breeden, MA, CRA sparo@dhha.org Telephone Number: 303.602.7046 777 Bannock Street, MC Denver, CO 80204-4057 Administrative Address: 777 Bannock Street, MC 1952 Denver, CO 80204-4057 Invoice Address: Denver Health P.O. Box 17093 Denver, CO 80217-0093 Reference: Activity No. DocuSign Envelope ID: BE296F94-60BA-4CE9-877E-CEAD4C9D575D i _ Attachment 3B Subrecipient Contacts i Subrecipient Information for FFATA reporting Entity's DUNS Name: Subaward Number: Al 8 -0055 -S008 -A02 EIN No.: DUNS: Parent DUNS: Place of Performance Address Institution Type: Currently registered in SAM.gov: O Yes O No Exempt from reporting executive compensation:O Yes© No (if no, complete 3Bpg2) This section for U.S. Entities: Congressional District: Zip Code Look -up Zip Code+4: i Subrecipient Contacts Central Email: Website: Principal Investigator Name: N/A Email: Administrative Contact Name: Email: Telephone Number: Financial Contact Name: Telephone Number: Email: Invoice/Payment Email: Authorized Official Name: Email: Telephone Number: Telephone Number: Legal Address: Administrative Address: Payment Address: DocuSign Envelope ID: BE296F94-60BA-4CE9-877E-CEAD4C9D575D i _ Attachment 3B-2 Highest Compensated Officers i Subaward Number: A18 -0055 -S008 -A02 Subrecipient: Institution Name: PI Name: Weld County Department of Public Health and Environment N/A Highest Compensated Officers The names and total compensation of the five most highly compensated officers of the entity(ies) must be listed if the entity in the preceding fiscal year received 80 percent or more of its annual gross revenues in Federal awards; and $25,000,000 or more in annual gross revenues from Federal awards; and the public does not have access to this information about the compensation of the senior executives of the entity through periodic reports filed under section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. §§ 78m(a), 78o(d)) or section 6104 of the Internal Revenue Code of 1986. See FFATA § 2(b)(1) Internal Revenue Code of 1986. Officer 1 Name: Officer 1 Compensation: Officer 2 Name: Officer 2 Compensation: Officer 3 Name: Officer 3 Compensation: Officer 4 Name: Officer 4 Compensation: Officer 5 Name: Officer 5 Compensation: DocuSign Envelope ID: BE296F94-60BA-4CE9-877E-CEAD4C9D575D Attachment 4 Reporting and Prior Approval Terms Subaward Number: Al 8 -0055 -S008 -A02 Subrecipient agrees to submit the following reports (PTE contacts are identified in Attachment 3A): Technical Reports: E Monthly technical/progress reports will be submitted to the PTE's of the end of the month. Principal Investigator within 15 days of Quarterly technical/progress reports will be submitted within 30 days after the end of each project quarter to the PTE's I Principal Investigator I Annual technical / progress reports will be submitted within 30 days prior to the end of each budget period to the PTE's Principal Investigator . Such report shall also include a detailed budget for the next Budget Period, updated other support for key personnel, certification of appropriate education in the conduct of human subject research of any new key personnel, and annual IRB or IACUC approval, if applicable. A Final technical/progress report will be submitted to the PTE's Principal Investigator within 30 days of the end of the Project Period or after termination of this award, whichever comes first. Technical/progress reports on the project as may be required by PTE's to satisfy its reporting obligations to the Sponsor. Principal Investigator in order for the PTE Prior Approvals: Carryover: Carryover is restricted for this subaward by the: Submit carryover requests to the Financial Contact Pass -Through Entity Other Reports: LiIn accordance with 37 CFR 401.14, Subrecipient agrees to notify PTE's days after Subrecipient's inventor discloses invention(s) in writing to Subrecipient's personnel responsible for patent matters. The Subrecipient will submit a finpl invention report using Sponsor specific forms to the PTE's Authorized Official I within 60 days of the end of the Project Period to be included as part of the PTE's final invention report to the Sponsor. A negative report is required: Authorized Official 30 No riProperty Inventory Report (only when required by Sponsor), specific requirements below. Other Special Reporting Requirements: DocuSign Envelope ID: BE296F94-60BA-4CE9-877E-CEAD4C9D575D i _ Attachment 5 Statement of Work, Cost Sharing, Indirects & Budget Subaward Number: Al 8 -0055 -S008 -A02 Statement of Work ©Below ()Attached, I ! pages If award is FFATA eligible and SOW exceeds 4000 characters, include a Subrecipient Federal Award Project Description Budget Information Indirect Information Indirect Cost Rate (IDC) Applied Rate Type: Modified Total Direct Costs 14.93 Cost Sharing No If Yes, include Amount: $ Budget Details Q Below Q Attached, pages Budget Totals Direct Costs $ Indirect Costs $ Total Costs $ 35, 016.00 5,228.00 40,244.00 All amounts are in United States Dollars DocuSign Envelope ID: BE296F94-60BA-4CE9-877E-CEAD4C9D575D Subaward Number: A18 -0055 -S008 -A02 O Attachment 6 Prime Award and any additional documents The following pages include the Prime Award and if applicable any additional documentation referenced throughout this Subaward. Not incorporating the Prime Award or any additional documentation to this Subaward. DocuSign Envelope ID: BE296F94-60BA-4CE9-877E-CEAD4C9D575D Attachment 5 WELD COUNTY DEPARTMENT OF PUBLIC HEALTH AND ENVIRONMENT SCOPE OF WORK This scope of work applies to the Cancer, Cardiovascular, and Chronic Pulmonary Disease Program (CCPD) with grant monies received from the Colorado Department of Public Health and Environment. Amount: $40,244 Period of Performance: July 01, 2021 — June 30, 2022 Definitions: 1. ACCORDS: Adult and Child Consortium for Health Outcomes Research and Delivery Science 2. ACIP: The Advisory Committee on Immunization Practices 3. Advisory Council: The Alliance Advisory Council is a group of subject matter experts who contributeto identifying gaps, new needs, and growth for our project. The Advisory Council's goal is to strengthen interagency connections by aligning stakeholder goals andstrategies that address challenges to increased HPV vaccination rates. 4. AFIX: Assessment, Feedback, Incentives, and eXchange Program from the Centers for Disease Control and Prevention (CDC) is an immunization quality improvement (QI) process designed to increase immunization coverage rates, decrease m issed opportunities to vaccinate, and improve standards of immunization practices atthe provider clinic level. 5. Affiance: The Affiance for HPV Free Colorado; this collaborative Affiance is comprised ofgrant subcontractors, state andlocal immunization programs, public andprivate health providers, academic institutions, medical societies, professional organizations addressing immunizations and cancer prevention, youth -serving organizations, and immunization advocacy groups. The Alliance encompasses all committees and groups on our project. 6. Affiance Communications Committee: The Communications Committee will develop and implement a regional public information campaign andprovide quarterly reports to the Affiance. 7. Affiance Dental Workgroup: The Dental Workgroup will oversee development of the framework and materials to help dentists improve their supportof the HPV vaccine. 8. Affiance Health Systems Committee: The Health Systems Committee will oversee, create and implement a plan to help health systems utilize quality improvement approaches to engage providers and strengthentheir recommendation for HPV vaccination. 9. Affiance Education Workgroup: The Education Workgroup will oversee development of provider education series, training of local public health departments, and implementation of practice intervention 10. Alliance Rural/FrontierAdaptation Workgroup: The Rural/Frontier Adaptation Workgroup will oversee adaptation of communications and health systems materials for Tura l a nd frontier Colorado. 11. Affiance Steering Committee: The Steering Committee exists to oversee, manage a nd gu ide the overall grant, including the work of the Advisory Council andall subcommittees. 12. BCPH: Boulder County Public Health 13. CCC HPV Task Force: Colorado Cancer Coalition HPV Vaccination Task Force 14. CCPD: Cancer, Cardiovascular Disease, and Pulmonary Disease Grants Program 15. CDC: Centers for Disease Control and Prevention 16. CDPHE: Colorado Department of Public Health and Environment 17. CI IS: Colorado Immunization Information System 18. DHHA: Denver Health andHospital Authority 19. DPH: Denver Public Health 20. Fifteen county jurisdiction: Adams, Arapahoe, Boulder, Broomfield, Denver, Douglas, Jefferson, Larimer, Logan, Morgan, Phillips, Sedgwick, Washington, Weld and Yuma counties 21. HPV: Human Papillomavirus 22. IC: Immunize Colorado Page 1of6 DocuSign Envelope ID: BE296F94-60BA-4CE9-877E-CEAD4C9D575D Attachment 5 23. JCPH: Jefferson County Public Health 24. LPHA: Local Public Health Agency 25. NCHD: Northeast Colorado Health Department 26. OutreachRoadmap: Document outlining plan for reaching out to and gaining buy -in from health systems partners that may be interested in working with the Alliance to improve vaccination rates. 27. QI: Quality Improvement 28. RCCOs/RAEs: Regional Care Collaborative Organizations/Regional Accountable Entities 29. SMART: Specific, Measurable, Achievable, Realistic, and Timely 30. WCDPHE: Weld County Department ofPublic Health and Environment Quarter timelines: Quarter 1: July 1 -September 30 Quarter 2: October 1 -December 31 Quarter 3 : January 1 -March 31 Quarter 4: April 1 -June 30 Project Title: Alliance for HPV Free Colorado Principal Investigator: Judith Shlay Program Manager: Tiffany Jerrod As a sub -contractor of DHHA, WCDPHE will perform the following scope of work related to the implementation and ongoing management ofthe CCPD grant "Alliance for HPV Free Colorado." Scope of work assignments are delineated by the approved HPV Alliance work plan for the following objectives and activities of the project. Deliverables are the responsibility of the staff appointed by WCDPHE. Goal: No later than the expiration date of this contract, the Alliance for HPV Free Colorado aims to implement a multidisciplinary approach that results in a sustainable increase in completion of the HPV vaccine series for 9-17 year -olds in a fifteen county region. Our four objectives are to: 1. Utilize community and partner stakeholders, including an HPV Advisory Council, to promote and champion HPV vaccine education and awareness, 2. Plan and implement a health systems approach to increase adherence to national HPV vaccination guidelines among practices and providers, 3. Adapt and implement a targeted communications plan to increase demand for and knowledge about the HPV vaccine among parents/guardians of adolescents aged 9-17 years, and 4. Utilize sustainable analytic infrastructure to measure HPV vaccination rates. Work Plan: Page 2 of 6 DocuSign Envelope ID: BE296F94-60BA-4CE9-877E-CEAD4C9D575D Attachment 5 Objective #1 Utilize community and partner stakeholders, including an HPV Advisory Council, to promote and champion HPV vaccine education and awareness. Primary Activity #2 (Steering Committee) The Subcontractor shall participate in the Affiance Steering Committee and complete applicable administrative activities. Sub -Activities 1. The Subcontractor shall participate in regularly scheduled Steering Committee meetings and complete resulting meeting action items as assigned. 2. The Subcontractor shall participate in project strategic planning sessions. 3. The Subcontractor shall partic ipate in regular Alliance subcommittee engagement and satisfaction surveys. 4. The Subcontractor shall provide data for proj ect evaluation reports as requested. 5. The Subcontractor shall support the Affiance in updating project sustainability plan. Primary Activity#1 (Advisory Council) The Subcontractor shall participate in the Affiance Advisory Council. Sub -Activities 1. The Subcontractor shall attend regularly scheduled quarterly HPV Advisory Council meetings, including subcommittee members as requested. 2. The Subcontractor shall plan, prepare and facilitate agenda items if requested. 3. The Subcontractor shall complete the Advisory Coun cil m ember engagement survey. Objective #2 Adapt and implementa health systems approach to increase adherence to national HPV vaccination guidelines among practices and providers. Primary Activity#1 (Health Systems) The Subcontractor shall assist in implementing a health systems approach to increase adherence to national HPV vaccination guidelines among practices and providers. Sub -Activities 1. The Subcontractor shall participate in regularly scheduled Health System Committee meetings. 2. The Subcontractor shall support LPHAs in connecting with, identifying, andtargetinghealth systems using the outreach roadmap. 3. The Subcontractor shall help update the outreach roadmap based on feedback from health systems and committee members. 4. The Subcontractor shall identify training n eeds for individuals who will be working with health systems to inform a training for effectively guiding systems on HPV vaccination best practices. 5. The Subcontractor shall help update the implementation plan based on feedback from health systems and committee members. 6. The Subcontractor shall help finalize andexecutethe health systems evaluationplan. Primary Activity #2 (Education) The Subcontractor shall participate in regularly scheduled Education Workgroup meetings. Sub -Activities 1. The Subcontractor shall support adaptations to educational materials andkeep up to date on most recent HPV-relatedresearch and information. 2. The subcontractor shall help plan a minimum of two (2) engagement activities (conference attendance, stakeholder meetings, etc.) to increase engagement with health systems outside of the formal education efforts. 3. The Subcontractor shall collect and input relevant survey data after tra in ings are complete. 4. The Subcontractor shall help lead education training sessions with Workgroup m embers, as needed. 5. The Subcontractor shall collaborate with Health Systems Committee to plan and train individuals and systems in implementing health systems interventions related to educational or practice intervention activities. 6. The Subcontractor shall collaborate with the Health Systems Committee to provide training for identified health systems' staff and providers engaging in HPV work. 7. The Subcontractor shall help plan andparticipate in a minimum of one (1) engagement activity Page 3 of 6 DocuSign Envelope ID: BE296F94-60BA-4CE9-877E-CEAD4C9D575D Attachment5 to increase engagement from new partners. Objective #3 Adapt and implementa targeted communications planto increase demand for and knowledge about the HPV vaccine among parents/guardians of adolescents aged 9 -17 years. Primary Activity #1 (Communications) The Subcontractor shall participate in regularly scheduled Communications Committee meetings. Sub -Activities 1 1. The Subcontractor shall review results of the FY22 paid, earned, and owned m edia campaigns metrics and offer recommendations for improvements. 2. The Subcontractor shall assist in planning and implementing an evaluation of the paid media campaign. 3. The Subcontractor shall review the results of the evaluation and offer recommendations for improvements. 4. The Subcontractor shall help lead research efforts, including planning, leading and analyzing focus groups/community engggementstudios, for adapting communications campaign for prioritized communities. 5. The Subcontractor shall use results from research to provide input on updating marketing campaign. 6. The Subcontractor shall participate in reviews of requests to share the campaign with other organizations on a case -by -case basis. 7. The Subcontractor shall participate in campaign dissemination efforts, such as presentations phone calls, or articles. 8. The Subcontractor shall be prepared to and will take on specific duties of the Committee Chair, as agreed upon by the Committee, should the Chair fall sick, go on vacation or otherwise be unable to execute their duties during a specific period of time. 9. The Subcontractor shall support the Health Systems Committee, Dental Workgroup, and Education Workgroup in executing relevant communications materials. Objective #4 Utilize sustainable analytic infrastructure to measure HPV vaccination rates. Primary Activity#1 (Everyone) The subcontractor shall assist with utilization,maintenance, and su stainability planning of IBIS. Sub -Activities #5 1. The Subcontractor shall provide analytic consulting expertise as needed. 2. The Subcontractor shall assist with reviewing and interpreting data reports for subcommittees' use, including evaluation, population -level and practice -level reports. 3. The Subcontractor shall provide feedback on an IBIS sustain ability plan, assessing future of IBIS andHPV data needs. 4. The Subcontractor shall provide feedback on exploring effectiveness of using CIIS and IBIS to track health system level data. Deliverables: Steering Committee The Subcontractor shall submit an electronic Progress Report to the Program Manager when requested. No later than 5days before end ofQ1,Q2,Q3,and Q4. The Subcontractor shall submit responses to all participant engagement and satisfaction surveys following Advisory Council and relevant Alliance committees and workgroups. No later than 5days before end ofQ2andQ4. The Subcontractor shall subm it feedback on the final sustainability plan. No later than 5 days before end of Q1. Page 4 of 6 DocuSign Envelope ID: BE296F94-60BA-4CE9-877E-CEAD4C9D575D Attachment 5 The Subcontractor shall submit feedback on the population -level HPV vaccination reports The Subcontractor shall submit the names and locations of thehealth systems invited and committed to working with Alliance. The Subcontractor shall submit feedback on materials created guide for effectively guiding system son HPV vaccination best practices. The Subcontractor shall submit feedback on updated fac ilitator guide. The Subcontractor shall submit feedback on finalhealth systems evaluation report. The Subcontractor shall submit feedback on updated outreach roadmap for engaging healthcare systems in promoting HPV vaccination. No later than 5 days before end of Q4. Health Systems No later than 5 days before endof Q1, Q2, Q3, and Q4. No later than 5 days before end of Q l . No later than 5 days before end of Ql . No later than 5 days before endof Q4. No laterthan5 days before end of Q1. Communications The Subcontractor shall submit feedback on web site usage. The Subcontractor shall submit feedback on pre -campaign evaluation results and final paid, earned, and ownedmedia plans. The Subcontractor shall subm it feedback on pre -campaign evaluation results and final paid, earned, and ownedmedia reports. The Subcontractor shall submit feedback on the website usage report. No later than 5 days before end of Q3. No later than 5 days before endof Q3. No later than 5 days before end of Q4. No laterthan 5 days before end of Q4. Method of Accountability: Subcontractor will attendmeetings and submit quarterly progress reports when requested. Budget: Personnel Posiitlon Salary Fringe (38.93%) % Effort 8 months Cost Health Educator/Navigator $83,621 $ 10% 12 $8,362 Immunization RN Educator $65,597 $ 8% 12 $5,248 CommunicationsSpecialist/PIO $83,621 $ 5% 12 $4,181 Program Administrator/Supervisor $141,499 $ 5% 12 $7,075 Subtotal Salaries $9,680 $34,546 qtr Expenses . t. Cost per # Mileage $0.56 482 Miles $270 Office/Other Operating Supplies $120 $120 Health systems materials $20 4 practices $80 Page 5 of 6 DocuSign Envelope ID: BE296F94-60BA-4CE9-877E-CEAD4C9D575D Attachment 5 Food/snacks for provider visits $ $ Subtotal Other $470 Total Direct Cost (TDC) $35,016 Indirect@ 14.93% $5,228 Total $40,244 AU or Activity to be charged: AU 43028221 Collaborative Agreement Because the Affiance forHPV Free Colorado is a collaborative effort among multiple organizations, it is imperativethat each subcontracting organization actively communicate with DPH staff and other subcontracted organizations regarding the progress of deliverable and activity completion. As part ofcommunicatingtheprogress o f de liverable completion, each subcontracting organization will participate in efforts to publish best practices and outcomes of our strategies. Payment Terms Invoices Electronic invoices should be submittedwithin 30 days of each month to the Program Manager, Tiffany Jen'oa Ti ffany.Jerrod@dhhcx org and Nikki.Pham@dhhcz org. Page 6 of 6 Contract Form New Contract Request Entity Information Entity Name* DENVER HEALTH AND HOSPITAL AUTHORITY Contract Name* Entity ID* Cv000151 39 ❑ New Entity? Contract ID DENVER HEALTH ALLIANCE FOR HPV FREE COLORADO 5080 Contract Status CTB REVIEW Contract Lead* KJAKUS-HOTCHKISS Contract Lead Email kjakus- hotc hkis s Pwe Idgov.com Parent Contract ID Requires Board Approval YES Department Project I Contract Description* DENVER HEALTH & HOSPITAL AUTHORITY ALLIANCE FOR HPV FREE COLORADO FY21 -22 FDP REIMBURSEMENT SUBAWARD AGREEMENT Al 8-0055-5008-A02 Contract Description 2 FY20-21 SUBAWARD AGREEMENT Al 8-0055-5048-A01 Contract Type AGREEMENT Amount* 540,244.00 Renewable NO Automatic Renewal NO Grant YES ICA NO Department HEALTH Department Email CM-HealthAAweldgov.corn Department Head Email CM -Health- Does Contract require Purchasing Dept. to be included? DeptHeadcTWeldgov.com NO Requested BOCC Agenda Date * 08,q09, 2021 Due Date 08:O5;`2021 Will a work session with BOCC be required?* HAD County Attorney GENERAL COUNTY A I I ORNEY EMAIL County Attorney Email CM- COUNTYA r I ORNEYWELDG OV.COM Grant Deadline Date If this is a renewal enter previous Contract ID 3999 If this is part of a MSA enter MSA Contract ID Note: the Previous Contract Number and Master Services Agreement Number should be left blank if those contracts are not in OnBase Contract Dates Effective Date 07/01;2021 Termination Notice Period Contact Information Contact Info Contact Name Purchasing basing Approver Approval Process Department Head TANYA GEISER DH Approved Date 08:02/2021 Final Approval BOCC Approved BOCC Signed Date BOCC Agenda Date 08,<09, 2021 Originator KJAKUS-HOTCHKISS Review Date* 04;`01 ,' 2022 Committed Delivery Date. Contact Type Finance Approver CHRIS D'OV1D1O Renewal Date Expiration Date 06;30 2022 it Contact Phone 1 Purchasing Approved Date Legal Counsel KARIN MCDOUGAL Finance Approved Date 08;02'2021 Tyler Ref it AG 080921 Contact Phone 2 Legal Counsel Approved Date O8;'04:2021 Hello